Whilst the harbouring of the APOE ε4 haplotype remains the greatest genetic risk factor for late onset AD, multiple genome-wide genetic association studies have highlighted the potential role of the innate immune system in the development of AD [3,4,5,6]. This evidence concerns the gene APOE and Alzheimer disease.